Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FQRQ2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,414.50 by the Defense Logistics Agency on September 23, 2025, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, which carries an ultimate completion date of October 15, 2025, was issued without a set-aside designation. The contract leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, demonstrating consistent success in competing for and executing delivery orders covering diverse medical products ranging from contraceptive devices to oncology treatments and specialty pharmaceuticals. The company's portfolio of federal contract awards reflects its operational capacity to deliver both branded and generic prescription drugs, biologics, and medical consumables to military healthcare systems across the nation. This particular delivery order for Nexplanon implants exemplifies the vendor's role in supporting the contraceptive and family planning needs of the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FQRQ2?
SPE2DB25FQRQ2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FQRQ2 worth?
The government has obligated $10,415 on SPE2DB25FQRQ2.
Is contract SPE2DB25FQRQ2 an order under another contract?
Yes. SPE2DB25FQRQ2 is a delivery order under SPE2DB20D9201, an indefinite delivery contract.
Was contract SPE2DB25FQRQ2 competed?
The extent of competition for SPE2DB25FQRQ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award